The KID Study. I: Structural baseline characteristics of the Federal Insurance for Salaried Employees' Institution (BfA) diabetic patients in inpatient rehabilitation. Kissingen Diabetes Intervention Study.
% of type I diabetics are not administering insulin according to the intensified conventional therapy schedules, only 16.8% of all type II diabetics are treated with diet only. Type II diabetics are much too often treated with pre-mixed insulins of too high dosage (26.2%) or with oral hypoglycemics (46.2%) of which 90% were sulphonylureas and nearly exclusively glibenclamide. Oral hypoglycemics with extrapancreatic activity or combined therapies were not common among the patients.
Haupt
E
E
Saale-Klinik der BfA, Bad Kissingen, Germany.
Herrmann
R
R
Benecke-Timp
A
A
Vogel
H
H
Hilgenfeldt
J
J
Haupt
A
A
Walter
C
C
D000328:Adult; D002096:C-Peptide / Q000097:blood; D002318:Cardiovascular Diseases / Q000097:blood / Q000150:complications; D003404:Creatinine / Q000097:blood; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood* / Q000534:rehabilitation*; D004651:Employment; D005260:Female; D005858:Germany; D006442:Glycated Hemoglobin / Q000378:metabolism; D006077:Government Agencies; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007297:Inpatients / Q000523:psychology; D007348:Insurance, Health; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D012709:Serum Albumin / Q000378:metabolism
D002096:C-Peptide; D003404:Creatinine; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D008055:Lipids; D012709:Serum Albumin